All regulatory updates
894 results found
ECHA Candidate List table to remain updated until July 2026 during migration of regulatory lists to ECHA CHEM
ECHA’s Candidate List table pages display an official transition notice indicating that regulatory list information is moving to the ECHA CHEM platform, while the legacy Candidate List dataset/table will continue to be kept up to date until July 2026 to support a smooth transition. This is compliance-relevant operational guidance: teams relying on the legacy Candidate List endpoints for SVHC screening (e.g., Article 33 communication workflows and internal substance monitoring) should plan and validate migration of bookmarks, integrations, and data pulls to ECHA CHEM, while noting the legacy table remains maintained only through July 2026.
EPA Prioritizes Data Center Chemical Reviews under TSCA
EPA announced a policy to prioritize review of new chemicals used in data center projects under TSCA. This prioritization supports American manufacturing and technological advancement by accelerating TSCA review timelines for chemicals essential to data center operations.
ECHA sets 2026 milestones and plans spring 2026 consultation on SEAC draft opinion for proposed EU-wide PFAS restriction
ECHA communicated process milestones for the proposed EU-wide REACH restriction on PFAS, including that SEAC expects to agree its draft opinion around March 2026 and that ECHA plans a 60‑day consultation in spring 2026 on the SEAC draft opinion. ECHA also indicates RAC opinion adoption is expected around March 2026 and that SEAC’s final opinion is expected by end of 2026. For companies placing PFAS-containing substances/mixtures/articles on the EU market, this signals a near-term opportunity/need to submit socio-economic and use information during the spring 2026 consultation, and to monitor forthcoming RAC/SEAC opinions that will shape the European Commission’s eventual restriction decision.
ECHA plans 60-day consultation on SEAC draft opinion for proposed EU-wide PFAS restriction after March 2026 SEAC meeting
ECHA announced it plans to launch a 60-day stakeholder consultation on the SEAC draft opinion for the proposed EU-wide PFAS restriction under REACH, following SEAC’s March 2026 meeting. ECHA notes the consultation will use a structured survey format and will not accept attachments, which affects how companies should prepare impact/alternatives information. Compliance teams should plan internal data gathering (uses, alternatives, socio-economic impacts) to respond within the consultation window once opened.
ECHA to run 60-day consultation on SEAC draft opinion on EU-wide PFAS restriction in spring 2026
ECHA announced plans to consult (60 days) on SEAC’s draft opinion for the proposed EU-wide PFAS restriction following SEAC’s March 2026 meeting. This notice is directly relevant for stakeholders preparing submissions on socio-economic impacts, uses, and alternatives. Compliance teams should plan to assemble use information, substitution timelines, and cost/benefit inputs in advance of the consultation window.
European Commission draft delegated directive proposes restructuring Annex III exemption 7(a) (lead in high-melting-temperature solders) into sub-entries
A European Commission draft delegated directive (C(2025) 5939 final, dated 8 Sep 2025) proposes amending Directive 2011/65/EU (RoHS) Annex III exemption 7(a) for “lead in high melting temperature type solders” (lead-based alloys containing ≥85% Pb by weight). The draft would split the current broad exemption into multiple, more specific sub-entries (7(a)-I to 7(a)-VII) aligned to defined application areas (e.g., internal interconnections, die attach, first-/second-level solder joints, hermetic sealing, certain lamps, audio transducers). For compliance teams, this signals a likely future need to re-map product uses currently claimed under legacy 7(a) to the correct new sub-entry and to track potentially different validity/expiry and renewal evidence expectations per sub-entry once adopted/published.
Delegated Directive (EU) 2025/2363 updates lead in glass/ceramics exemption
Commission Delegated Directive (EU) 2025/2363, dated 8 September 2025, amends Annex III of Directive 2011/65/EU regarding exemptions for lead in glass or ceramic components. Manufacturers using lead in glass or ceramic components in electrical and electronic equipment should review the updated exemption scope, validity periods, and any new sub-entry structuring to ensure continued compliance.
European Commission delegated directive package proposes/sets restructuring of Annex III exemption 7(a) (lead in high-melting-temperature solders) into sub-entries
A European Commission delegated directive package (Commission document dated 8 Sep 2025) indicates an amendment to Directive 2011/65/EU (RoHS) Annex III regarding exemption 7(a) for lead in high-melting-temperature solders. The package describes revising the wording and splitting exemption 7(a) into multiple more specific sub-entries (described as 7(a)-I through 7(a)-VII) to better define scope by application area and enable more targeted future assessments/renewals. Compliance teams relying on Annex III 7(a) should be prepared to map current uses to the new sub-entry structure and reassess exemption-claim documentation once the delegated directive is finalized/published in the Official Journal.
European Commission publishes draft delegated directive restructuring Annex III exemption 7(a) (lead in high-melting-temperature solders) into sub-entries
The European Commission issued a draft delegated directive (Commission document dated 8 Sep 2025) proposing to amend Directive 2011/65/EU by restructuring Annex III exemption 7(a) (lead in high-melting-temperature solders) into multiple sub-entries (e.g., 7(a)-I to 7(a)-VII) tied to specific application areas. For compliance teams, this signals a forthcoming change in how products relying on exemption 7(a) must be mapped and justified (more granular applicability conditions), and may affect exemption-renewal dossier strategy and evidence needs. The draft also reiterates procedural expectations (e.g., renewal applications due no later than 18 months before expiry; exemptions generally remain valid while a timely renewal is pending).
Commission document (C(2025) 5939 final) describes amending Annex III exemption 7(a) on lead in high-melting-temperature solders by restructuring into sub-entries
A Commission Delegated Directive document (C(2025) 5939 final) in the Commission transparency register describes an amendment to Directive 2011/65/EU (RoHS) Annex III concerning the exemption for lead in high-melting-temperature solders (historically exemption 7(a)). The document indicates a restructuring approach that splits the exemption into multiple sub-entries (I–VII) to clarify scope and support more granular assessment/management. Compliance teams using high-Pb high-melting solders should prepare for exemption applicability to be tied to specific sub-entry conditions once the measure is finalized/published in the Official Journal.
Commission Delegated Directive draft amends Annex III lead exemption 7(a) (high melting temperature solders) by restructuring into sub-entries
A European Commission transparency-register document (dated 8 September 2025) describes a delegated directive intended to amend Directive 2011/65/EU (RoHS) Annex III exemption 7(a) for lead in high-melting-temperature solders. The document indicates the exemption would be restructured into multiple sub-entries (7(a)-I to 7(a)-VII) to better define scope and uses (e.g., different application areas such as interconnections, die attach, sealing and certain lamps/components). Compliance teams relying on exemption 7(a) should monitor the final adopted delegated directive/Official Journal publication and align product documentation to the revised exemption sub-scope once confirmed.
BIS revokes Validated End-User authorizations in the People's Republic of China
BIS revoked Validated End-User (VEU) authorizations for certain entities in the People's Republic of China. Entities that previously benefited from VEU authorizations must now obtain individual export licenses for covered items. Exporters should verify current authorization status before proceeding with transactions.
BIS relaxes export controls for Syria to support humanitarian and civil society activities
BIS relaxed certain export controls for Syria to facilitate humanitarian assistance and support civil society activities. The changes reflect evolving U.S. policy toward Syria and create new licensing opportunities for previously restricted transactions while maintaining appropriate safeguards.
DOE Issues FAL 2025-08 on Buy America Preference Implementation
DOE issued Financial Assistance Letter (FAL) 2025-08 providing updated implementation guidance for the Buy America Preference requirement under BABA. The guidance is applicable to all DOE financial assistance awards for public infrastructure projects and includes waiver request submittal and review processes. FAL 2025-08 supersedes FAL 2025-01.
Northern Ireland urges small business EPR registration before 2026 deadline
DAERA urged small businesses to register for the Extended Producer Responsibility (EPR) scheme. Companies in Northern Ireland with annual turnover over £1 million responsible for more than 25 tonnes of packaging annually must record and report packaging data. Businesses must submit nation data for 2025 calendar year by April 1, 2026.
ECHA announces target to complete scientific evaluation of proposed EU-wide PFAS restriction by end of 2026
ECHA published a timeline update indicating that its committees aim to complete the scientific evaluation of the proposed EU-wide REACH restriction on PFAS by the end of 2026. This is a procedural milestone (not an adopted restriction) that helps companies forecast when RAC/SEAC opinions may be finalized and when the European Commission could proceed toward a draft restriction decision, enabling earlier planning for potential substitution, essential-use justifications, and stakeholder participation.
ECHA announces timeline for PFAS restriction evaluation; objectives include SEAC consultation in H1 2026 and delivering final opinions in 2026
ECHA issued an official timeline update for the evaluation of the proposed EU-wide REACH PFAS restriction. ECHA states planning objectives to run the SEAC draft opinion consultation in the first half of 2026 and to deliver final RAC/SEAC opinions to the European Commission in 2026. This is a process/timeline signal rather than a binding restriction, but it is important for compliance planning (substitution roadmaps, supplier engagement, and commenting readiness).
ECHA announces target to complete scientific evaluation of proposed REACH PFAS restriction by end of 2026
ECHA published an official timeline update stating it aims to complete the scientific evaluation of the proposed EU-wide PFAS restriction under REACH by the end of 2026. This is a process/timeline signal (not a final restriction), but it is relevant for compliance planning because it frames when committee opinions and subsequent European Commission decision-making could mature. Companies should align internal resourcing (alternatives analyses, socio-economic inputs, supply chain mapping) to the expected 2026 evaluation milestones.
ECHA sets target to complete scientific evaluation of EU-wide PFAS restriction by end of 2026
ECHA published an update on the REACH restriction process for the proposed EU-wide (class-based) PFAS restriction, stating a target to complete the scientific evaluation by the end of 2026. This is a key planning milestone for companies tracking potential future EU restrictions across product categories and industrial uses, informing internal timelines for substitution assessments, supply-chain engagement, and data gathering ahead of committee opinions and subsequent Commission action.
OEHHA proposes NSRLs for 1-bromopropane and diethanolamine
OEHHA proposed amendments to Title 27, California Code of Regulations, Section 25705(b) to adopt No Significant Risk Levels (NSRLs) for 1-bromopropane (54 micrograms per day) and diethanolamine for dermal exposure (6.4 micrograms per day). The diethanolamine NSRL applies only to dermal routes of exposure. The public comment period was extended to November 7, 2025 at the request of industry stakeholders.